This flower wouldn't hurt anyone, I'm sure its just delightful

You can find the full transcript on Thomas More’s website. For brevity and commentary purposes, here are the bits I find most concerning. As you should find them.

Ruth: Well you know the thing that I notice is that the clinics that are offering second-trimester services because of the crazy PBA bill a number of years ago, digoxin is in heavy use. Because with ditch, you have fetal death, you’re never gonna have a live birth.

In other words, in order to procure good parts, the baby has to be delivered alive. Right? Because that’s the conclusion I’m drawing here.

Ruth: And so, most people by 19, 20 weeks, if they’re seeing cases beyond 20, 22, 24 weeks, they want to make certain that they have total fetal demise, and in a counseling way, it’s wonderful for women, because they don’t have to worry about fetal pain during the procedure. You know, even if it’s incorrect, it’s still in their brains, because the antis have been doing that forever.

The anti-choice people. Yeah, how terrible of us to say killing babies is wrong. Our bad.

Ruth: So, finding the clinics that aren’t using digoxin for the later cases is the trickier part.

Tricky, but not impossible. If there’s extra money to be made from unborn babies, gotta take it.

Ruth: Yeah. Now, a lot of places, not a lot, some researchers are looking for whole fetuses, in the earlier stages, so you over-dilate, you try to be able to extract an entire fetus through your cannula, but then again, the over-dilation can be a risk to the woman, so you know, it’s a game.

There it is. Right there. Whole fetuses require the over-dilation of the woman to extract a baby whole. Partial-birth abortion, everyone. Right there. Delivering a baby whole to harvest it for its parts. And all of hell rejoiced.

Tech: So they sometimes will change the procedure a little bit. Ruth: Yep. Mhm. They certainly will. And just, it really depends on, sometimes the medical director, the clinic owner, whoever wants to work with you guys, and then it’s the physicians, you know, how much am I willing to alter any of my processes?

But wait, because it gets worse. How? Here’s how:

Ruth: And then some, well there’s one doc in New York, he’s in Manhattan, he’s a physician who sees patients through 24 weeks, and they may see some fetal-maternal indications patients a week or two beyond that. His routine is not digoxin, he does a clamp the cord, and wait, for just a minute or two.

This “doctor” has a name: David Gluck. The reason other “doctors” do not follow the clamp the cord and kill the child slowly procedure is, unlike digoxin, the clamp cord method takes time.

Ruth: It is. And if you don’t have the time, if you’re not able to get the cord, get it appropriately, I mean, digoxin is pretty fail-safe. And it’s not something that the woman has to worry about. She knows when the baby’s gonna die.

Various articles delve into whether van Gogh’s later works including so much yellow color was due to side effects of digoxin. Here’s one article by Anna Gruener.

Art and sight are closely intertwined. Painting is a visual medium that requires both the artist and the observer to use their visual sense to fully appreciate the execution and development of a composition.

Various theoretical arguments have been advanced, attesting to the extent that visual problems allegedly have influenced a particular artist’s work product.

Researchers tracked a combination of worsening heart failure episodes and cardiovascular deaths. While patients taking digoxin experienced 19% fewer total events, the difference failed to reach statistical significance, meaning it could have occurred by chance. The drug showed no advantage in reducing cardiovascular deaths specifically. The findings challenge earlier hints that lower doses of digoxin might help without the safety concerns linked to higher levels. Although the treatment proved safe and caused few side effects, it did not meet the study's primary goal. For patients with reduced heart function, the results leave questions about whether this historic medication deserves a place alongside newer therapies. Digoxin stands as one of cardiovascular medicine's oldest drugs. Yet significant new research suggests it can not provide the clear benefit doctors had hoped for in modern heart failure treatment. The DECISION trial followed 1,001 patients with chronic heart failure for over three years, comparing low-dose digoxin against a placebo.